Results 61 to 70 of about 33,475 (169)

What do we know about nephrotoxicity of NSAIDs in horses?

open access: yes
Equine Veterinary Education, EarlyView.
C. Di Donato, G. van Galen
wiley   +1 more source

Temporary caval occlusion technique during right divisional hepatectomy for massive hepatocellular carcinoma with caudal vena cava compression/involvement in dogs

open access: yesVeterinary Surgery, Volume 55, Issue 8, Page 1375-1386, November 2026.
Abstract Objective To describe the perioperative and long‐term outcomes of dogs with massive hepatocellular carcinoma (HCC) in the right hepatic division causing compression or involvement of the caudal vena cava (CVC) treated with right divisional hepatectomy using temporary caval occlusion (TCO). Study design Retrospective case series.
Kumiko Ishigaki   +6 more
wiley   +1 more source

Dobutamine-induced stress affects intracellular uptake of manganese : a quantitative magnetic resonance imaging study in pigs

open access: yes, 2004
PURPOSE: To determine whether there are differences in increase in longitudinal relaxation rate (DeltaR1) in the myocardium between bolus administration of Mn(2+) ions during rest and during dobutamine-induced stress and, additionally, to determine ...
Johansson, Lars,   +7 more
core   +1 more source

Dobutamine improves afterload-induced deterioration of mechanical efficiency toward maximal

open access: yes, 1992
We studied the effect of increased afterload on the ratios of O2 consumption (VO2) to external work (EW), VO2 to the systolic pressure-volume area (PVA), and PVA to EW at control state and with dobutamine in the left ventricles of open-chest dogs.
M. Fujita   +5 more
core   +1 more source

Dobutamine pharmacodynamics during dobutamine stress echocardiography and the impact of β-blocker withdrawal: A report from the women\u27s ischemic syndrome evaluation study

open access: yes, 2002
Study Objectives. To determine the pharmacodynamic parameters of dobutamine during dobutamine stress echocardiography (DSE) and to determine how β-blocker withdrawal the evening before DSE affects responses to dobutamine during DSE. Design. Retrospective
Johnson, Julie A.   +11 more
core   +1 more source

β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography

open access: yes, 2008
Our objective was to determine if β1-adrenergic receptor (β1-AR) and β2-AR gene polymorphisms influence heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) response to dobutamine during dobutamine stress echocardiography ...
Terra, S. G.   +15 more
core   +1 more source

Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography [PDF]

open access: yes, 2007
A continuous infusion of a single high dose of dobutamine has been, recently, suggested as a simple and effective protocol of stress echocardiography.
Herribert Pavaci   +11 more
core   +2 more sources

Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure

open access: yes, 2015
Background Ivabradine is a heart rate (HR)-lowering agent acting by inhibiting the I-f-channel. Dobutamine does increase the HR and has some deleterious effects on myocardium.
ÇAVUŞOĞLU, YÜKSEL   +5 more
core   +1 more source

The Effect of Pimobendan on Myocardial Mechanical Function and Metabolism in Dogs: Comparison with Dobutamine

open access: yes, 1991
The effect of pimobendan, a newly developed cardiotonic agent, on myocardial mechanical function and energy metabolism has been examined in the dog heart, and compared with that of dobutamine.
Kazuo Ichihara, Yasushi Abiko
core   +1 more source

Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine

open access: yes, 2008
Levosimendan and dobutamine are comparable inotropic drugs as regards their hemodynamic effects and clinical outcomes in decompensated heart failure (HF).
Tek, Mujgan   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy